AAAAAA

   
Results: 1-11 |
Results: 11
High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy - II. Validation of a direct injection/on-line guard cartridge extraction-tandem mass spectrometry method for CYP2D6 inhibition assessment
Authors: Bu, HZ Magis, L Knuth, K Teitelbaum, P
Citation: Hz. Bu et al., High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy - II. Validation of a direct injection/on-line guard cartridge extraction-tandem mass spectrometry method for CYP2D6 inhibition assessment, J CHROMAT B, 753(2), 2001, pp. 321-326
High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1
Authors: Bu, HZ Magis, L Knuth, K Teitelbaum, P
Citation: Hz. Bu et al., High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1, RAP C MASS, 15(10), 2001, pp. 741-748
High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy - V. Validation of a direct injection/on-line guard cartridge extraction-tandem mass spectrometry method for CYP1A2 inhibition assessment
Authors: Bu, HZ Knuth, K Magis, L Teitelbaum, P
Citation: Hz. Bu et al., High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy - V. Validation of a direct injection/on-line guard cartridge extraction-tandem mass spectrometry method for CYP1A2 inhibition assessment, EUR J PH SC, 12(4), 2001, pp. 447-452
High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy: III. Validation of a direct injection/on-line guard cartridge extraction - tandem mass spectrometry method for CYP2C19 inhibitionevaluation
Authors: Bu, HZ Knuth, K Magis, L Teitelbaum, P
Citation: Hz. Bu et al., High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy: III. Validation of a direct injection/on-line guard cartridge extraction - tandem mass spectrometry method for CYP2C19 inhibitionevaluation, J PHARM B, 25(3-4), 2001, pp. 437-442
Flaws within travel medicine
Authors: Teitelbaum, P
Citation: P. Teitelbaum, Flaws within travel medicine, J TRAVEL M, 7(2), 2000, pp. 100-101
High-throughput cytochrome P450 inhibition screening via cassette probe-dosing strategy. IV. Validation of a direct injection on-line guard cartridgeextraction/tandem mass spectrometry method for simultaneous CYP3A4, 2D6 and 2E1 inhibition assessment
Authors: Bu, HZ Knuth, K Magis, L Teitelbaum, P
Citation: Hz. Bu et al., High-throughput cytochrome P450 inhibition screening via cassette probe-dosing strategy. IV. Validation of a direct injection on-line guard cartridgeextraction/tandem mass spectrometry method for simultaneous CYP3A4, 2D6 and 2E1 inhibition assessment, RAP C MASS, 14(20), 2000, pp. 1943-1948
High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy. I. Development of direct injection/on-line guard cartridge extraction/tandem mass spectrometry for the simultaneous detection of CYP probe substrates and their metabolites
Authors: Bu, HZ Magis, L Knuth, K Teitelbaum, P
Citation: Hz. Bu et al., High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy. I. Development of direct injection/on-line guard cartridge extraction/tandem mass spectrometry for the simultaneous detection of CYP probe substrates and their metabolites, RAP C MASS, 14(17), 2000, pp. 1619-1624
Granulysin, a T cell product, kills bacteria by altering membrane permeability
Authors: Ernst, WA Thoma-Uszynski, S Teitelbaum, P Ko, C Hanson, DA Clayberger, C Krensky, AM Leippe, M Bloom, BR Ganz, T Modlin, RL
Citation: Wa. Ernst et al., Granulysin, a T cell product, kills bacteria by altering membrane permeability, J IMMUNOL, 165(12), 2000, pp. 7102-7108
The pharmacokinetics and safety profile of oral ganciclovir in combinationwith trimethoprim in HIV- and CMV-seropositive patients
Authors: Jung, D AbdelHameed, MH Hunter, J Teitelbaum, P Dorr, A Griffy, K
Citation: D. Jung et al., The pharmacokinetics and safety profile of oral ganciclovir in combinationwith trimethoprim in HIV- and CMV-seropositive patients, BR J CL PH, 47(3), 1999, pp. 255-259
The pharmacokinetics and safety profile of oral ganciclovir combined with zalcitabine or stavudine in asymptomatic HIV- and CMV-seropositive patients
Authors: Jung, D AbdelHameed, MH Teitelbaum, P Dorr, A Griffy, K
Citation: D. Jung et al., The pharmacokinetics and safety profile of oral ganciclovir combined with zalcitabine or stavudine in asymptomatic HIV- and CMV-seropositive patients, J CLIN PHAR, 39(5), 1999, pp. 505-512
The Hague Appeal for Peace Conference - Reflections on 'civil society' andNGOs
Authors: Stoett, P Teitelbaum, P
Citation: P. Stoett et P. Teitelbaum, The Hague Appeal for Peace Conference - Reflections on 'civil society' andNGOs, INT J, 55(1), 1999, pp. 35-44
Risultati: 1-11 |